Low expression of ascitic ATX was associated with clinically meaningful improvements in short PFS and OS in patients with HGSOC, thus suggesting that high ascitic ATX levels could predict unfavourable outcome in patients with ovarian cancer. The gene discussed is ENPP2; the disease is ovarian cancer.